Effects of cilomilast on dendritic cell function in contact sensitivity and dendritic cell migration through skin

European Journal of Pharmacology

Volumn 481, Issue 2-3, 2003, Pages 271-279

  Bäumer, Wolfgang ^a   Tschernig, Thomas ^b   Sülzle, Boris ^a   Seegers, Ulrike ^a   Lührmann, Anke ^b   Kietzmann, Manfred ^a  

^a UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Cilomilast; Dendritic cell; Matrix metalloproteinase 9; Phosphodiesterase 4 inhibitor; Skin, mouse; Toluene 2,4 diisocyanate; Zymography

Indexed keywords

CILOMILAST; PHOSPHODIESTERASE IV INHIBITOR; TOLUENE DIISOCYANATE;

ALLERGIC REACTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; CELL FUNCTION; CELL INTERACTION; CELL MIGRATION; CONTACT SENSITIVITY; CONTROLLED STUDY; DENDRITIC CELL; EAR; EDEMA; FEMALE; INCUBATION TIME; MOUSE; NONHUMAN; PRIORITY JOURNAL; SENSITIZATION; SKIN ALLERGY; T LYMPHOCYTE;

EID: 0344827151     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2003.09.031     Document Type: Article

References (24)

1. Asahina A., Moro O., Hosoi J., Lerner E.A., Xu S., Takashima A., Granstein R.D. Specific induction of cAMP in Langerhans cells by calcitonin gene-related peptide: relevance to functional effects. Proc. Natl. Acad. Sci. U. S. A. 92:1995;8323-8327.
2. Bancherau J., Steinman R.M. Dendritic cells and the control of immunity. Nature. 392:1998;245-252.
3. Bäumer W., Gorr G., Hoppman J., Ehinger A.M., Ehinger B., Kietzmann M. Effects of the phosphodiesterase 4 inhibitors SB 207499 and AWD 12-281 on the inflammatory reaction in a model of allergic dermatitis. Eur. J. Pharmacol. 446:2002;195-200.
4. Belleguic C., Corbel M., Germain N., Boichot E., Delaval P., Lagente V. Reduction of matrix metalloproteinase-9 activity by the selective phosphodiesterase 4 inhibitor, RP 73-401 in sensitized mice. Eur. J. Pharmacol. 404:2000;369-373.
5. Chujor S.N.C., Hammerschmid F., Lam C. Cyclic nucleotide phosphodiesterase 4 subtypes are differentially expressed by primary keratinocytes and human epidermoid cell lines. J. Invest. Dermatol. 110:1998;287-291.
6. Corbel M., Germain N., Lanchou J., Molet S., Silva P.M.R.E., Martins M.M., Boichot E., Lagente V. The selective phosphodiesterase 4 inhibitor RP 73-401 reduced matrix metalloproteinase 9 activity and transforming growth factor-β release during acute lung injury in mice: the role of the balance between tumour necrosis factor-α and interleukin 10. J. Pharmacol. Exp. Ther. 301:2002;258-265.
7. Gantner F., Schudt C., Wendel A., Hatzelmann A. Characterization of the phosphodiesterase (PDE) pattern of in vitro-generated human dendritic cells (DC) and the influence of PDE inhibitors on DC function. Pulm. Pharmacol. Ther. 12:1999;377-386.
8. Giembycz M.A. Cilomilast: a second generation phosphodiesterase 4 inhibitor for asthma and chronic obstructive pulmonary disease. Expert Opin. Investig. Drugs. 10:2001;1361-1379.
9. Hatzelman A., Schudt C. Anti-inflammatory and immunomodulatory potential of the novel PDE4 inhibitor roflumilast in vitro. J. Pharmacol. Exp. Ther. 297:2001;267-279.
10. Kambayashi T., Wallin R.P., Ljunggren H.G. cAMP-elevating agents suppress dendritic cell function. J. Leukoc. Biol. 70:2001;910-930.
11. Kellermann S.-A., Hudak S., Oldham E.R., Liu Y.-J., Mcevoy L.M. The CC chemokine receptor-7 ligands 6Ckine and macrophage inflammatory protein-3 β are potent chemoattractants for in vitro- and in vivo derived dendritic cells. J. Immunol. 162:1999;3859-3864.
12. Kobayashi Y. Langerhans' cells produce type IV collagenase (MMP-9) following epicutaneous stimulation with haptens. Immunology. 90:1997;496-501.
13. Kobayashi Y., Matsumoto M., Kotani M., Makino T. Possible involvement of matrix metalloproteinase-9 in Langerhans cell migration and maturation. J. Immunol. 163:1999;5989-5993.
14. Kohyama T., Liu X., Zhu Y.K., Wen F.Q., Fang Q., Kobayashi T., Rennard S.I. Phosphodiesterase 4 inhibitor cilomilast inhibits fibroblast-mediated collagen gel degradation induced by tumor necrosis factor-alpha and neutrophil elastase. Am. J. Respir. Cell Mol. Biol. 27:2002;494-497.
15. Krasteva M., Kehren J., Horand F., Akiba H., Choquet G., Ducluzeau M.-T., Tedone R., Garrigue J.-L., Kaiserlian D., Nicolas J.-F. Dual role of dendritic cells in the induction and down-regulation of antigen-specific cutaneous inflammation. J. Immunol. 160:1998;1181-1190.
16. Krasteva M., Kehren J., Ducluzeau M.-T., Sayag M., Cacciapuoti M., Akiba H., Descotes J., Nicolas J.-F. Contact dermatitis: I. Pathophysiology of contact dermatitis. Eur. J. Dermatol. 9:1999;65-77.
17. Lutz M.B., Kukutsch N., Ogilvie L., Rossner S., Koch F., Romani N., Schuler G. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods. 223:1999;77-92.
18. Lutz M.B., Schnare M., Menges M., Rössner S., Röllinghoff M., Schuler G., Gessner A. Differential functions of IL-4 receptor types I and II for dendritic cell maturation and IL-12 production and their dependency on GM-CSF. J. Immunol. 169:2002;3574-3580.
19. Makela M., Salo T., Larjava H. MMP-9 from TNF alpha-stimulated keratinocytes binds to cell membranes and type I collagen: a cause for extended matrix degradation in inflammation? Biochem. Biophys. Res. Commun. 253:1998;325-335.
20. Mattei M., Carnieri E., Politi V., D'Alessio S., Sella A., Cassol M., Robeva A., Colizzi V., Sumerska T. Inhibition of contact hypersensitivity reaction to picryl chloride: effects of small molecular weight peptidomimetic compounds possessing inhibitory activity against metalloproteinases. Int. Immunopharmacol. 2:2002;699-710.
21. Mizumoto N., Kumamoto T., Robson S.C., Sevigny J., Matsue H., Enjyoji K., Takashima A. CD 39 is the dominant Langerhans cell-associated ecto-NTPDase: modulatory roles in inflammation and immune responsiveness. Nat. Med. 8:2002;358-365.
22. Ortner U., Inaba K., Koch F., Heine M., Miwa M., Schuler G., Romani N. An improved isolation method for murine migratory cutaneous dendritic cells. J. Immunol. Methods. 193:1996;71-79.
23. Ratzinger G., Stoitzner P., Ebner S., Lutz M.B., Layton G.T., Rainer C., Senior R.M., Shipley J.M., Fritsch P., Schuler G., Romani N. Matrix metalloproteinases 9 and 2 are necessary for the migration of Langerhans cells and dermal dendritic cells from human and murine skin. J. Immunol. 168:2002;4361-4371.
24. Wang M., Qin X., Mudgett J.S., Ferguson T.A., Senior R.M., Welgus H.G. Matrix metalloproteinase deficiencies affect contact hypersensitivity: Stromelysin-1 deficiency prevents the response and gelatinase B deficiency prolongs the response. Proc. Natl. Acad. Sci. U. S. A. 96:1999;6885-6889.